Icagen, Inc. Receivables Turnover Ratio (ICGND), from the third quarter 2019 to the third quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Icagen, Inc.  (ICGND)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Icagen Accounts Receivables Turnover Ratio from the third quarter 2019 to the third quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Icagen, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2019 to a ratio of 9.95, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the third quarter 2019. Average receivable collection period, for the Icagen in Sep 30 2019 quarter, has decreased to 37 days, compared to 45 days, in the Jun 30 2019 quarter.

If we take a look into Healthcare sector 125 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2019 from 1119 to 1371.

What is Receivable Turnover Ratio?
What is Icagen, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ICGND Receivables Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Receivable Change -51.34 % -25.25 % -12.14 % 17.9 % 0.56 %
Y / Y Revenue Change 19.66 % -10.75 % 12.31 % -44.71 % -44.52 %
Receivable Turnover Ratio (TTM) 9.95 8.13 7.88 7.47 9.25
ICGND's Total Ranking # 1371 # 1119 # 1119 # 1213 # 277
Accounts Receivable average collection period days 37 45 46 49 39
Seq. Receivable Change -30.69 % -1.74 % -33.89 % 8.07 % 6.47 %
Seq. Revenue Change -7.84 % 12.86 % 10.98 % 3.67 % -31.26 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 3
Healthcare Sector # 126
Overall Market # 1371

Receivable Turnover Ratio Statistics
High Average Low
17.71 9.07 4.21
(Jun 30 2013)   (Mar 31 2016)





ICGND Company Profile • Back to ICGND Efficiency Comparisons • Compare ICGND Receivables Turnover Ratio to its Competitors

Financial Statements
Icagen's Accounts Receivable $ 1 Millions Visit ICGND's Balance sheet
Icagen's Sales TTM $ 14 Millions Visit ICGND's Income Statement
Sources of ICGND's Revenues Visit ICGND's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ICGND's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ICGND's Growth Rates ICGND's Roa ICGND's Inventory Turnover Ratio ICGND's Dividend Comparisons
ICGND's Profitability Ratios ICGND's Roi ICGND's Asset Turnover Ratio ICGND's Dividend Growth
ICGND's Valuation Ratios ICGND's Roe ICGND's Financial Strength Ratios ICGND's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Receivable at quarter ending Sep 30 2019
Arrowhead Pharmaceuticals Inc   41.03 $ 168.796  Millions$ 4.114  Millions
Vbi Vaccines Inc  40.96 $ 4.331  Millions$ 0.106  Millions
Zeo Scientifix Inc   40.87 $ 1.702  Millions$ 0.042  Millions
Innovation1 Biotech Inc   40.27 $ 0.079  Millions$ 0.002  Millions
Fate Therapeutics Inc   38.16 $ 9.539  Millions$ 0.250  Millions
Health right Discoveries Inc   37.73 $ 3.894  Millions$ 0.103  Millions
Optinose Inc   35.96 $ 26.573  Millions$ 0.739  Millions
Wearable Health Solutions, Inc.  35.70 $ 1.696  Millions$ 0.048  Millions
Guardion Health Sciences Inc   35.55 $ 0.899  Millions$ 0.025  Millions
Ironwood Pharmaceuticals inc   35.40 $ 432.804  Millions$ 12.226  Millions
Zymeworks Inc   31.91 $ 56.592  Millions$ 1.774  Millions
Cardiff Lexington Corporation  31.39 $ 4.513  Millions$ 0.144  Millions
National Vision Holdings Inc   30.96 $ 1,678.490  Millions$ 54.212  Millions
Brookdale Senior Living Inc   29.93 $ 4,122.695  Millions$ 137.731  Millions
Diversicare Healthcare Services Inc   29.91 $ 528.017  Millions$ 17.653  Millions
Telesis Bio Inc   29.41 $ 5.096  Millions$ 0.173  Millions
Healthlynked Corp  28.80 $ 3.353  Millions$ 0.116  Millions
Cyclo Therapeutics Inc   27.54 $ 1.019  Millions$ 0.037  Millions
Regeneron Pharmaceuticals Inc   26.44 $ 7,621.697  Millions$ 288.225  Millions
Creative Medical Technology Holdings Inc   25.81 $ 0.227  Millions$ 0.009  Millions
Advanced Container Technologies Inc   24.95 $ 1.994  Millions$ 0.080  Millions
Dariohealth Corp   24.52 $ 7.461  Millions$ 0.304  Millions
Endonovo Therapeutics Inc   24.44 $ 0.204  Millions$ 0.008  Millions
Cytomx Therapeutics Inc   23.91 $ 60.681  Millions$ 2.538  Millions
Ernexa Therapeutics Inc   23.48 $ 20.541  Millions$ 0.875  Millions
Igc Pharma Inc   23.44 $ 6.297  Millions$ 0.269  Millions
Cormedix Inc   23.15 $ 0.285  Millions$ 0.012  Millions
Ibio inc   22.87 $ 2.081  Millions$ 0.091  Millions
Harrow Inc   21.84 $ 49.945  Millions$ 2.287  Millions
Tearlab Corp  20.98 $ 22.997  Millions$ 1.096  Millions

Date modified: 2026-10-07T00:41:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.